1. Home
  2. BFS vs CDNA Comparison

BFS vs CDNA Comparison

Compare BFS & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BFS

Saul Centers Inc.

HOLD

Current Price

$31.94

Market Cap

759.2M

Sector

Real Estate

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$19.20

Market Cap

712.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFS
CDNA
Founded
1993
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
759.2M
712.2M
IPO Year
1993
2014

Fundamental Metrics

Financial Performance
Metric
BFS
CDNA
Price
$31.94
$19.20
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$26.67
AVG Volume (30 Days)
75.9K
800.2K
Earning Date
11-06-2025
11-04-2025
Dividend Yield
7.39%
N/A
EPS Growth
N/A
N/A
EPS
1.14
1.22
Revenue
$282,618,000.00
$357,998,000.00
Revenue This Year
$8.14
$14.11
Revenue Next Year
$5.75
$12.00
P/E Ratio
$27.99
$15.79
Revenue Growth
5.61
14.46
52 Week Low
$29.16
$10.96
52 Week High
$40.47
$25.95

Technical Indicators

Market Signals
Indicator
BFS
CDNA
Relative Strength Index (RSI) 55.95 58.36
Support Level $31.42 $19.21
Resistance Level $32.37 $20.05
Average True Range (ATR) 0.59 0.88
MACD 0.11 -0.09
Stochastic Oscillator 67.30 53.65

Price Performance

Historical Comparison
BFS
CDNA

About BFS Saul Centers Inc.

Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: shopping centers, which contribute the maximum portion of total revenue; and mixed-use properties. Maximum tenants include grocery stores, discount department stores, and drug stores.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: